Notable Analyst Rating Changes 11/14: CLX, LDK, ALO, URBN Upgraded; GSK, EMR, LHO, UDR Downgraded
UPGRADES:
Goldman Sachs upgrades Clorox Co. (NYSE: CLX) from Sell to Neutral
Morgan Stanley upgrades LDK Solar (NYSE: LDK) from Equal Weight to Overweight, but trimmed their price target from $42 to $23.
Cowen & Co upgrades Alpharma (NYSE: ALO) from Neutral to Outperform.
Stifel Nicolaus upgrades Urban Outfitters (Nasdaq: URBN) from Hold to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
UBS downgrades GlaxoSmithKline (NYSE: GSK) from Buy to Neutral.
J.P. Morgan downgrades Emerson (NYSE: EMR) from Neutral to Underweight.
BB&T and JMS Securities downgraded LaSalle Hotel Properties (NYSE: LHO) to Hold and Neutral, respectively.
BMO Capital downgrades UDR Inc. (NYSE: UDR) from Outperform to Market Perform.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Keegan initiates coverage on Nokia (NYSE: NOK) with a Market Perform.
Morgan Keegan initiates coverage on Garmin (Nasdaq: GRMN) with a Market Perform.
Banc of America initiated coverage on Schering-Plough (NYSE: SGP) and Pfizer (NYSE: PFE) with Buy ratings today.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
Related Entities
- Stifel Nicolaus
- UBS
- JPMorgan
- Goldman Sachs
- Morgan Stanley
- Banc of America
- BMO Capital
- BB&T Capital Markets
- Morgan Keegan & Company
- Notable Analyst Rating Changes
- Cowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
